Identifikation und immunologische Charakterisierung von MHC ...

6. Literaturverzeichnis
inhibitor survivin with different antiapoptotic properties. Cancer Res. 59: 6097-
6102.
Mapara, MY and Sykes, M. (2004). Tolerance and cancer: mechanisms of tumor
evasion and strategies for breaking tolerance. J. Clin. Oncol. 22: 1136-1151.
Marchand, M., van Baren, N., Weynants, P., Brichard, V., Dreno, B., Tessier,
MH, Rankin, E., Parmiani, G., Arienti, F., Humblet, Y., Bourlond, A., Vanwijck,
R., Lienard, D., Beauduin, M., Dietrich, PY, Russo, V., Kerger, J., Masucci, G.,
Jäger, E., De Greve, J., Atzpodien, J., Brasseur, F., Coulie, PG, van der Bruggen,
P. and Boon, T. (1999). Tumor regressions observed in patients with metastatic
melanoma treated with an antigenic peptide encoded by gene MAGE-3 and
presented by HLA-A1. Int. J. Cancer 80: 219-230.
Matzinger, P. (1994). Tolerance, danger, and the extended family. Annu. Rev.
Immunol. 12: 991-1045.
Melief, CJ, Offringa, R., Toes, RE and Kast, WM (1996). Peptide-based cancer
vaccines. Curr. Opin. Immunol. 8: 651-657.
Menges, M., Rossner, S., Voigtlander, C., Schindler, H., Kukutsch, NA,
Bogdan, C., Erb, K., Schuler, G. and Lutz, MB (2002). Repetitive injections of
dendritic cells matured with tumor necrosis factor alpha induce antigen-
specific protection of mice from autoimmunity. J. Exp. Med. 195(1): 15-21.
Molldrem, JJ, Dermime, S., Parker, K., Jiang, YZ, Mavroudis, D., Hensel, N.,
Fukushima, P. and Barrett, AJ. (1996). Targeted T-cell therapy for human
leukemia: cytotoxic T lymphocytes specific for a peptide derived from
proteinase 3 preferentially lyse human myeloid leukemia cells. Blood 88(7):
2450-2457.
112